Traditional Chinese medicine fumigation combined with Levofloxacin for type ⅢA prostatitis with the symptoms of damp heat and blood stasis.
- Author:
Xing-Zhi YANG
1
;
Yu GUO
1
;
Wei XIONG
1
;
Jie LI
2
;
De-Gui CHANG
3
;
Pei-Hai ZHANG
4
;
You WANG
1
;
Xi WANG
1
;
Xiao-Hong DAI
1
Author Information
1. Department of Urology, Chongqing Hospital of Traditional Chinese Medicine, Chongqing 400021, China.
2. Department of Endocrinology, Chongqing Hospital of Traditional Chinese Medicine, Chongqing 400021, China.
3. Department of Andrology, The Second Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 610041, China.
4. Department of Andrology, Sichuan Provincial Hospital of Integrated Chinese and Western Medicine, Chengdu, Sichuan 610041, China.
- Publication Type:Journal Article
- Keywords:
Levofloxacin;
National Institute of Health Chronic Prostatitis Symptom Index;
Traditional Chinese medicine fumigation;
Levofloxacin;
symptoms of damp heat and blood stasis;
type ⅢA prostatitis
- MeSH:
Anti-Bacterial Agents;
administration & dosage;
Chronic Disease;
Drugs, Chinese Herbal;
administration & dosage;
Fumigation;
Hot Temperature;
Humans;
Levofloxacin;
administration & dosage;
Male;
Medicine, Chinese Traditional;
Prostatitis;
drug therapy;
pathology;
Severity of Illness Index;
Symptom Assessment;
methods
- From:
National Journal of Andrology
2017;23(2):173-177
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the clinical effects of traditional Chinese medicine (TCM) fumigation on type ⅢA prostatitis with the symptoms of damp heat and blood stasis.
METHODS:We randomly divided 72 cases of type ⅢA prostatitis with the symptoms of damp heat and blood stasis into an experimental and a control group of equal number, the former treated with TCM fumigation plus oral Levofloxacin while the latter with oral Levofloxacin only. After 4 weeks of treatment, we compared the National Institute of Health Chronic Prostatitis Symptom Index (NIHCPSI) score, TCM symptoms score, maxinum flow rate (Qmax), and average urinary flow rate (Qave) between the two groups of patients.
RESULTS:The total effectiveness rate was significantly higher in the experimental than in the control group (91.7% vs 61.1%, P< 0.01), while the NIHCPSI score in the experimental group was markedly decreased after treatment as compared with the baseline (14.5 ± 8.2 vs 26.5 ± 9.3, P< 0.05) and significantly lower than that in the control (14.5 ± 8.2 vs 20.6 ± 7.9, P< 0.05). Qmax was remarkably increased in the experimental group after treatment in comparison with the baseline (［21.2 ± 4.3］ vs ［15.8 ± 3.6］ ml/s, P< 0.05) and the control group, and so was Qave as compared with pretreatment (［16.3 ± 3.5］ vs ［10.5 ± 2.8］ ml/s, P< 0.05) and the control. However, the patients of the control group showed no statistically significant differences before and after treatment either in Qmax (［15.4 ± 3.4］ vs ［16.1 ± 2.9］ ml/s, P>0.05) or in Qave (［10.9 ± 2.4］ vs ［11.1 ± 2.9］ ml/s, P>0.05).
CONCLUSIONS:TCM fumigation combined with Levofloxacin is an effective therapy for type ⅢA prostatitis with the symptoms of damp heat and blood stasis, which can significantly improve the symptoms, reduce the NIHCPSI score, and increase the Qmax and Qave of the patient.
